Caricamento...
Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
In recent years, clinical research in the field of new treatments for chronic hepatitis C (HCV) has been devoted to developing regimens based on direct-acting antivirals (DAAs), with the goal of increasing treatment efficacy and improving tolerability and safety. This can be achieved by Peginterfero...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4010630/ https://ncbi.nlm.nih.gov/pubmed/24822024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HMER.S44375 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|